InterAct Therapeutics
Dallas, US · Founded 2025 · Delaware corporation
Founders & leadership
DH
Daniel HargroveinMr. Hargrove is the CEO and a director of the Issuer.
Board
IC
Isaac ChanDr. Chan is a director of the Issuer
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2026
▶$250KraisedJul 2026 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedJul 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel HargroveExecutive Officer, Director
- Isaac ChanDirector
- Offering amount
- $2M
- Amount sold
- $250K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has InterAct Therapeutics raised?
- InterAct Therapeutics has disclosed $250K raised across 1 round.
- Where is InterAct Therapeutics headquartered?
- InterAct Therapeutics is headquartered in Dallas, US.